[
  {
    "ts": "2025-10-31T22:29:00+00:00",
    "headline": "Alternative Economic Data Point to Solid Growth",
    "summary": "Washington may be closed for business, but the economy keeps humming. Plus, investment newsletter commentary on housing-market troubles, the oil-price outlook, and attractive dividend stocks.",
    "url": "https://www.barrons.com/articles/economy-stocks-divideds-housing-investing-66663431?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "77eaf6f5-d147-3ad1-bc6e-0fd1a465df5d",
      "content": {
        "id": "77eaf6f5-d147-3ad1-bc6e-0fd1a465df5d",
        "contentType": "STORY",
        "title": "Alternative Economic Data Point to Solid Growth",
        "description": "",
        "summary": "Washington may be closed for business, but the economy keeps humming. Plus, investment newsletter commentary on housing-market troubles, the oil-price outlook, and attractive dividend stocks.",
        "pubDate": "2025-10-31T22:29:00Z",
        "displayTime": "2025-10-31T22:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/77eaf6f5-d147-3ad1-bc6e-0fd1a465df5d/alternative-economic-data.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/b794174310fe439d0ba1da440b9d0934",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/z4cAicaWeK_.fg.GOemSmg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/b794174310fe439d0ba1da440b9d0934.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7A4fBTmAlNv1eCcS0ujWkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/b794174310fe439d0ba1da440b9d0934.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/economy-stocks-divideds-housing-investing-66663431?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TGT"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "IVZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T18:00:00+00:00",
    "headline": "The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot",
    "summary": "The Craneware Group convened leaders from 25 major U.S. health systems, alongside representatives from Beacon/ESP (Berkeley Research Group) and Apexus, the HRSA 340B Prime Vendor, at its U.S. headquarters this week to align on readiness for the now-approved 340B Rebate Model Pilot Program.",
    "url": "https://finance.yahoo.com/news/craneware-group-hosts-340b-rebate-180000144.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "c6fde06f-d746-35bb-b6b3-01494b0b611b",
      "content": {
        "id": "c6fde06f-d746-35bb-b6b3-01494b0b611b",
        "contentType": "STORY",
        "title": "The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot",
        "description": "",
        "summary": "The Craneware Group convened leaders from 25 major U.S. health systems, alongside representatives from Beacon/ESP (Berkeley Research Group) and Apexus, the HRSA 340B Prime Vendor, at its U.S. headquarters this week to align on readiness for the now-approved 340B Rebate Model Pilot Program.",
        "pubDate": "2025-10-31T18:00:00Z",
        "displayTime": "2025-10-31T18:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/6e72c71b4f34beb267dc2fdc804ebb1f",
          "originalWidth": 400,
          "originalHeight": 187,
          "caption": "TCG Logo (PRNewsfoto/The Craneware Group)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/84sCBOFrMRcX6FLybSl9WQ--~B/aD0xODc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6e72c71b4f34beb267dc2fdc804ebb1f.cf.webp",
              "width": 400,
              "height": 187,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vL6Y6i5p.8yA86bm2o4kog--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6e72c71b4f34beb267dc2fdc804ebb1f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/craneware-group-hosts-340b-rebate-180000144.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/craneware-group-hosts-340b-rebate-180000144.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRWRF"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T11:00:00+00:00",
    "headline": "Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer",
    "summary": "Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with KEYTRUDA with up to 30 patients per arm Company anticipates trial completion in early 2027, and potential updates in 2026 Additional updates from the ongoing Phase 1b/2 trial with muzastotug, previously reported at ASCO 2025, are anticipated in the coming months SAN DIEGO and SUZ",
    "url": "https://finance.yahoo.com/news/adagene-announces-first-patient-dosed-110000234.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "3295369c-2102-3cfc-a41e-a8a9f58d54b0",
      "content": {
        "id": "3295369c-2102-3cfc-a41e-a8a9f58d54b0",
        "contentType": "STORY",
        "title": "Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer",
        "description": "",
        "summary": "Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with KEYTRUDA with up to 30 patients per arm Company anticipates trial completion in early 2027, and potential updates in 2026 Additional updates from the ongoing Phase 1b/2 trial with muzastotug, previously reported at ASCO 2025, are anticipated in the coming months SAN DIEGO and SUZ",
        "pubDate": "2025-10-31T11:00:00Z",
        "displayTime": "2025-10-31T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/fe1e492df597a586d8304ad7fbea4a8b",
          "originalWidth": 440,
          "originalHeight": 386,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Km.iDUymrS8htWjo9.aZZg--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fe1e492df597a586d8304ad7fbea4a8b.cf.webp",
              "width": 440,
              "height": 386,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ND76FpkFurDCgVBykGeoxg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fe1e492df597a586d8304ad7fbea4a8b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/adagene-announces-first-patient-dosed-110000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/adagene-announces-first-patient-dosed-110000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ADAG"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T10:09:13+00:00",
    "headline": "Merck (MRK) Margin Expansion Tops Narratives With 19.4% EPS Growth and 25.8% Profit Margin",
    "summary": "Merck (MRK) delivered annual earnings growth of 19.4%, outpacing its own 5-year average growth rate of 13.4%. Profit margins moved higher for the period, standing at 25.8% versus 22% last year, continuing a five-year streak of consistent profit expansion and pointing to persistent earnings quality. With the company currently trading below its estimated fair value and offering a lower Price-to-Earnings ratio than its peers, investors may see value. A strong dividend and history of growth...",
    "url": "https://finance.yahoo.com/news/merck-mrk-margin-expansion-tops-100913509.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "dc2ac1ce-560f-3c0b-bbcb-9ad8c658d71d",
      "content": {
        "id": "dc2ac1ce-560f-3c0b-bbcb-9ad8c658d71d",
        "contentType": "STORY",
        "title": "Merck (MRK) Margin Expansion Tops Narratives With 19.4% EPS Growth and 25.8% Profit Margin",
        "description": "",
        "summary": "Merck (MRK) delivered annual earnings growth of 19.4%, outpacing its own 5-year average growth rate of 13.4%. Profit margins moved higher for the period, standing at 25.8% versus 22% last year, continuing a five-year streak of consistent profit expansion and pointing to persistent earnings quality. With the company currently trading below its estimated fair value and offering a lower Price-to-Earnings ratio than its peers, investors may see value. A strong dividend and history of growth...",
        "pubDate": "2025-10-31T10:09:13Z",
        "displayTime": "2025-10-31T10:09:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kA84g.s9IO2ClCgTX6BCgg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DmY770n7xz5DXLM6ZHLmxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-margin-expansion-tops-100913509.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-margin-expansion-tops-100913509.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]